PRESS RELEASE published on 05/19/2026 at 06:30, 2 months 22 days ago Formycon expands commercial portfolio: Aflibercept biosimilars Ahzantive® and Baiama® are now available in the European Union Formycon expands commercial portfolio with the launch of Aflibercept biosimilars Ahzantive(R) and Baiama(R) in the European Union, reinforcing market penetration and growth strategy Biosimilars Formycon European Union Aflibercept Commercial Portfolio
BRIEF published on 04/22/2026 at 06:35, 3 months 18 days ago Résultats financiers de Formycon pour 2025 et perspectives stratégiques pour 2026 Partenariats Stratégiques Prévisions Financières Pour 2026 Résultats De Formycon 2025 Progrès Des Projets De Biosimilaires Stratégie FYB4Growth
BRIEF published on 04/22/2026 at 06:35, 3 months 18 days ago Formycon's 2025 Financial Results and Strategic Outlook for 2026 Strategic Partnerships 2026 Financial Forecast Formycon 2025 Results Biosimilar Pipeline Progress FYB4Growth Strategy
PRESS RELEASE published on 04/22/2026 at 06:30, 3 months 18 days ago Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships Formycon AG reports successful financial year 2025 with operational progress, market growth, and strategic partnerships. Forecast for 2026 includes revenue growth and positive EBITDA Strategic Partnerships Formycon AG Operational Progress Market Presence Financial Year 2025
BRIEF published on 04/20/2026 at 06:35, 3 months 20 days ago Formycon annonce sa conférence téléphonique sur les résultats financiers de 2025 et ses conférences pour les investisseurs en 2026. Conseil D'administration Formycon AG Conférence Téléphonique Résultats Financiers 2025 Conférences Pour Investisseurs 2026
BRIEF published on 04/20/2026 at 06:35, 3 months 20 days ago Formycon Announces 2025 Financial Results Conference Call and 2026 Investor Conferences Conference Call Formycon AG Management Board Financial Results 2025 Investor Conferences 2026
PRESS RELEASE published on 04/20/2026 at 06:30, 3 months 20 days ago Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026 Formycon AG to hold Conference Call on Results of FY 2025 and participate in international Investor Conferences in Q2 2026. Details and registration at provided links Conference Call Investor Conferences Formycon AG Biosimilars Financial Year 2025
BRIEF published on 04/15/2026 at 19:57, 3 months 24 days ago Formycon AG Reports Improved Preliminary Figures for 2025 Fiscal Year Working Capital Annual Financial Statements Formycon AG 2025 Fiscal Year Group EBITDA
BRIEF published on 04/15/2026 at 19:57, 3 months 24 days ago Formycon AG annonce des résultats préliminaires améliorés pour l'exercice 2025. Formycon AG Fonds De Roulement États Financiers Annuels Exercice Financier 2025 EBITDA Du Groupe
PRESS RELEASE published on 04/15/2026 at 19:52, 3 months 24 days ago EQS-Adhoc: Formycon AG: Formycon AG announces improved preliminary figures for the 2025 fiscal year, including adjusted EBITDA and working capital, with annual financial statements publication set for April 22, 2026 Financial Statements EBITDA Formycon AG Preliminary Figures 2025 Fiscal Year
Published on 08/10/2026 at 15:30, 7 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 12 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 1 hour 7 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 2 hours 7 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 2 hours 37 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 15:25, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 08/10/2026 at 15:23, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 08/10/2026 at 11:53, 3 hours 43 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 3 hours 43 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 4 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 11:36, 4 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Published on 08/10/2026 at 09:47, 5 hours 49 minutes ago 260810 BENETEAU Transactions sur actions propres